Synovitis is inflammation of the synovial membrane, the thin tissue that lines the inside of most joints. It causes swelling, warmth, stiffness, and pain, and it shows up across a surprisingly wide range of conditions, from rheumatoid arthritis and osteoarthritis to gout, childhood hip pain, and rare tumors. While many people think of it as a symptom of joint disease, research over the past two decades has shifted the picture: synovitis can actually drive joint damage forward, not just accompany it.
What the Synovial Membrane Normally Does
The synovium is not just passive packaging around a joint. It is a metabolically active tissue made up mostly of loose connective tissue with a thin inner lining, typically only a few cells thick. That lining contains two main cell types: macrophage-like cells that clear debris and help regulate immune responses, and fibroblast-like cells that produce the lubricating fluid and maintain the structural scaffolding of the joint.
In a healthy joint, the macrophage-like cells (identifiable by the marker CD68) sit alongside fibroblast-like synoviocytes (marked by CD55), and together they keep the joint lubricated, nourished, and free of waste products.1Annals of the Rheumatic Diseases. Microarchitecture and protective mechanisms in synovial tissue from clinically and arthroscopically normal knee joints Even in normal synovium, some lining cells express immune-related markers like HLA-DR, which means the tissue is always at least mildly immunologically active, ready to respond if something goes wrong.2PubMed. The immunohistology of synovial lining cells in normal and inflamed synovium The trouble starts when that low-level readiness tips over into sustained inflammation.
How Synovitis Develops
When the synovium becomes inflamed, its thin lining thickens dramatically. Immune cells flood in, and the fibroblast-like synoviocytes begin behaving aggressively. Instead of quietly maintaining the joint’s extracellular matrix, they start churning out inflammatory signaling molecules and enzymes that break down cartilage.3PubMed Central. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis In rheumatoid arthritis, these fibroblast-like cells interact with immune cells to build organized clusters of inflammatory tissue within the joint, creating a self-sustaining loop of damage.4PubMed. Destructive Roles of Fibroblast-like Synoviocytes in Chronic Inflammation and Joint Damage in Rheumatoid Arthritis
As the inflamed synovium expands, it needs more blood supply. New blood vessels grow into the tissue in a process called angiogenesis, and the expanding mass of inflamed tissue, known as pannus, begins invading the cartilage and bone beneath it.5PubMed Central. Angiogenesis in rheumatoid arthritis Pro-inflammatory molecules like tumor necrosis factor (TNF) drive both the inflammation and the new blood vessel growth, which is why blocking TNF has become one of the most effective treatment strategies.6PubMed. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis The whole process feeds itself: inflammation triggers tissue growth, tissue growth demands more blood supply, and the richer blood supply brings more immune cells to fuel further inflammation.
The Main Conditions That Cause It
Synovitis is not a single disease. It is a feature of many different conditions, and the underlying trigger matters enormously for how it is treated.
Rheumatoid Arthritis
In rheumatoid arthritis, the synovium is where the core disease process plays out. The immune system attacks the joint lining, and if the resulting synovitis is not controlled, it leads to irreversible cartilage and bone damage.7PubMed Central. The synovium in rheumatoid arthritis Synovitis in RA tends to be symmetrical, affecting the same joints on both sides of the body, and it can persist for years if untreated. One study found that the presence of synovitis at baseline roughly doubled the risk of structural joint damage over time, whether detected by physical exam or ultrasound.8Annals of the Rheumatic Diseases. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound
Osteoarthritis
Osteoarthritis was long considered a purely “wear and tear” disease, with cartilage gradually thinning from mechanical stress. That picture has changed. Sensitive imaging and tissue studies have confirmed that synovial inflammation is present at all stages of osteoarthritis, and it is connected to pain, poor function, and the progression of joint damage.9PubMed Central. Synovitis in osteoarthritis: current understanding with therapeutic implications The synovium can show significant inflammatory changes even before visible cartilage damage has occurred, with thickening of the lining layer and infiltration of immune cells. This has led researchers to consider synovitis not just a consequence of cartilage breakdown but a possible independent driver of the disease.10PubMed Central. Synovial inflammation in osteoarthritis progression The inflammation in OA is subtler than in RA, often described as low-grade, and it can be clinically hard to detect without imaging.11PubMed Central. Role of low-grade inflammation in osteoarthritis
Crystal Arthritis
Gout and calcium pyrophosphate disease (sometimes called pseudogout) trigger acute synovitis when crystals deposit in the joint. In gout, monosodium urate crystals directly stimulate the synovial fibroblasts to produce the inflammatory molecule IL-1β through a specific inflammatory pathway called the NLRP3 inflammasome.12PubMed Central. Role of the NLRP3 inflammasome in the transient release of IL-1β induced by monosodium urate crystals in human fibroblast-like synoviocytes The result is a dramatic, painful flare that can come on within hours. Importantly, for many patients, the diagnosis of gout or calcium pyrophosphate arthritis cannot be confirmed without examining the synovial fluid directly under a microscope to identify the crystals.13PubMed. Synovial fluid analysis: Relevance for daily clinical practice
Transient Synovitis in Children
One of the most common causes of acute hip pain in children is transient synovitis, sometimes called “irritable hip.” It is a benign, self-limiting condition that typically causes a sudden limp or refusal to bear weight. Although the exact cause is unclear, it is widely thought to follow a viral infection. The key clinical challenge is distinguishing it from more serious conditions like septic arthritis. Transient synovitis is usually identified by the absence of fever combined with normal blood work and normal imaging, and it resolves on its own.14Journal of Pediatric Orthopaedics B. Transient synovitis of the hip: a comprehensive review
Pigmented Villonodular Synovitis
Pigmented villonodular synovitis (PVNS), now more commonly called tenosynovial giant cell tumor, is a rare condition where the synovium grows abnormally, forming masses that can damage cartilage and bone. Research has shown that overexpression of a growth factor called CSF1 is central to this condition. About 60% of cases have a specific genetic rearrangement that drives CSF1 production, while the remaining cases achieve the same result through other mechanisms.15The American Journal of Surgical Pathology. Translocation and Expression of CSF1 in Pigmented Villonodular Synovitis, Tenosynovial Giant Cell Tumor, Rheumatoid Arthritis and Other Reactive Synovitides The consistent involvement of CSF1 across all cases has opened the door to targeted therapies that block the CSF1 receptor, and drugs aimed at this pathway are now in clinical use for cases that cannot be surgically removed.
How Synovitis Is Detected
You might assume that a swollen, painful joint is obviously inflamed, but synovitis can be surprisingly hard to detect on physical exam alone, especially in osteoarthritis or in joints that are deep within the body. This is where imaging and laboratory testing come in.
Ultrasound and Power Doppler
Musculoskeletal ultrasound has become one of the most practical tools for spotting synovitis. It can detect thickening of the synovial lining and fluid accumulation in the joint. Adding Power Doppler, which shows blood flow within the tissue, takes this a step further: increased blood flow in the synovium is a sign of active inflammation. In one study comparing Doppler findings to tissue samples, a positive Doppler signal was present in about 83% of patients whose biopsies confirmed active inflammation.16PubMed Central. Power Doppler ultrasonography and synovitis: correlating ultrasound imaging with histopathological findings and evaluating the performance of ultrasound equipments
Ultrasound can also pick up synovitis that a standard clinical exam misses. This subclinical inflammation, invisible to the examining physician’s hands, still correlates with disease severity. In hand osteoarthritis, joints showing synovitis on ultrasound (especially those with a Power Doppler signal) had worse X-ray scores and thinner cartilage.17PubMed. Ultrasound-detected synovitis with power Doppler signal is associated with severe radiographic damage and reduced cartilage thickness in hand osteoarthritis Targeting treatment to eliminate Doppler-detected inflammation, rather than relying solely on how the patient feels, may lead to better long-term outcomes.18PubMed Central. The Role of Power Doppler Ultrasonography as Disease Activity Marker in Rheumatoid Arthritis
Synovial Fluid Analysis
Drawing fluid from the joint with a needle and examining it under a microscope remains indispensable for some diagnoses. Crystal-induced arthritis is the clearest example: identifying urate or calcium pyrophosphate crystals in the fluid provides a definitive answer that no imaging modality can match. Fluid analysis also helps narrow the differential when the cause of a swollen joint is unclear, distinguishing inflammatory from non-inflammatory and infectious from sterile processes.19PubMed. Synovial fluid analysis: Relevance for daily clinical practice
Blood Biomarkers
Standard blood tests like CRP and ESR give a general sense of inflammation but are not specific to the joints. A more targeted biomarker gaining traction is calprotectin, a protein released by activated immune cells. In rheumatoid arthritis patients, higher serum calprotectin tracks closely with swollen joint counts, disease activity scores, and the degree of synovitis visible on Power Doppler ultrasound.20PubMed Central. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis Even in patients on powerful immunosuppressive drugs that lower CRP (like IL-6 blockers or JAK inhibitors), calprotectin levels remain higher in those with active synovitis on ultrasound compared to those without, making it a useful tool when traditional markers are blunted by treatment.21PubMed Central. Plasma calprotectin as a biomarker of ultrasound synovitis in rheumatoid arthritis patients receiving IL-6 antagonists or JAK inhibitors
Treatment Approaches
How synovitis is treated depends entirely on what is driving it. For a gout flare, the answer might be a short course of anti-inflammatory medication. For transient synovitis in a child, it is usually rest and watchful waiting. The more complex treatment landscape surrounds chronic inflammatory conditions like rheumatoid arthritis, where synovitis is the central battleground.
Disease-Modifying Drugs and Biologics
The standard first-line approach in RA is disease-modifying antirheumatic drugs (DMARDs), with methotrexate being the most widely used. These medications slow joint damage and reduce symptoms for many patients, but a significant number continue to experience inflammation and progressive destruction despite DMARD therapy. That gap led to the development of biologic agents, which target specific molecules in the inflammatory cascade, including TNF, IL-1, and IL-6.22PubMed Central. Biologic agents in rheumatoid arthritis: an update for managed care professionals
One of the more striking findings in recent years is that the synovium itself may predict which biologic will work best for a given patient. Research examining synovial tissue has identified distinct molecular patterns. Patients whose synovitis is dominated by a myeloid (macrophage-driven) pattern tend to respond better to anti-TNF drugs, while those with a lymphoid (lymphocyte-driven) pattern respond better to anti-IL-6 therapy. In one study, patients with high myeloid markers had roughly three times the response rate to anti-TNF treatment compared to those with high lymphoid markers, and the reverse was true for IL-6 blockade.23PubMed Central. Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics This kind of tissue-based profiling is moving the field toward a more personalized approach, though it is not yet routine in clinical practice.
Synovectomy
When medications fail to control synovitis in a specific joint, surgical removal of the inflamed synovial tissue, called synovectomy, is sometimes considered. Arthroscopic (keyhole) synovectomy has shown clear advantages over open surgery: faster pain reduction, shorter hospital stays (roughly three days versus six), quicker return to daily activities, lower complication rates, and reduced postoperative inflammation.24PubMed Central. Minimally Invasive vs. Open Synovectomy in Rheumatoid Arthritis: Insights into Clinical Recovery, Systemic Inflammation, and Economic Impact In RA patients with knee synovitis that has not responded to medication, arthroscopic synovectomy has been shown to effectively reduce both acute and chronic inflammatory infiltrates and improve knee function at over two years of follow-up.25PubMed. Site-specific intraoperative efficacy of arthroscopic knee joint synovectomy in rheumatoid arthritis Synovectomy is not a cure for the underlying disease, and the synovium can regrow and become inflamed again, but it can buy significant relief when a single joint is causing disproportionate problems.
Synovitis That Happens Outside the Joint
The synovial membrane does not only line joint capsules. It also lines the sheaths that surround tendons, particularly in the hands and feet. When that tendon sheath becomes inflamed, the result is tenosynovitis, a condition common in RA that can cause pain, swelling along a tendon, and difficulty moving the fingers or toes. In RA, researchers have found that tenosynovitis and joint synovitis look remarkably similar under the microscope: the same lining thickening, the same immune cell infiltration, and the same patterns of inflammatory gene expression. The synovial fibroblasts isolated from inflamed tendon sheaths even behave like those from inflamed joints in lab studies, proliferating and producing the same inflammatory mediators.26PubMed Central. Comparative histopathological analysis between tenosynovitis and joint synovitis in rheumatoid arthritis The practical takeaway is that tenosynovitis in RA is not a separate process; it is the same disease affecting a different location, and it responds to the same systemic treatments.
Why Synovitis That Persists Matters
One of the most important findings for anyone living with inflammatory joint disease is that synovitis that continues after treatment starts is a strong predictor of future structural damage. The study mentioned earlier on RA found that when synovitis persisted four months into therapy, the risk of subsequent joint damage remained elevated compared to joints where the synovitis resolved.27Annals of the Rheumatic Diseases. The ability of synovitis to predict structural damage in rheumatoid arthritis: a comparative study between clinical examination and ultrasound This is why rheumatologists increasingly push for a “treat to target” approach, using ultrasound and biomarkers rather than relying only on how a patient feels. You can have active synovitis with relatively mild symptoms, and that smoldering inflammation still erodes cartilage and bone over time.
How Exercise Affects Synovial Inflammation
The relationship between physical activity and joint inflammation is not as straightforward as “rest good, movement bad.” Animal research has shown that a single bout of exercise changes the metabolic profile of the synovial fluid in ways that suggest both pro- and anti-inflammatory effects. Acute exercise appears to reduce prostaglandin production in the synovial fluid, which is an anti-inflammatory shift, while also affecting pathways related to blood flow regulation and catecholamine signaling.28Osteoarthritis and Cartilage Open. In vivo mechanotransduction: Effect of acute exercise on the metabolomic profiles of mouse synovial fluid
Mechanical loading of joints also has effects that extend beyond the joint itself. In animal models, loading a joint increased the number of immune cells in the nearby lymph nodes that produce both inflammatory and anti-inflammatory signals, suggesting the body mounts a calibrated immune response to normal mechanical stress.29Osteoarthritis and Cartilage. Mechanical loading of joint modulates T cells in lymph nodes to regulate osteoarthritis Even human studies have shown that walking on a treadmill transiently increases circulating levels of both inflammatory markers like TNF-α and anti-inflammatory ones like IL-10 in the blood.30PubMed Central. Low-Grade Inflammatory Mediators and Metalloproteinases Yield Synchronous and Delayed Responses to Mechanical Joint Loading The picture that emerges is that appropriate exercise triggers a balanced immune response rather than a purely damaging one, which aligns with clinical guidelines recommending moderate physical activity for people with osteoarthritis and rheumatoid arthritis rather than strict rest.
None of this means that any amount or type of exercise is safe for an acutely inflamed joint. During a severe flare of RA or a gout attack, forced movement can worsen pain and potentially accelerate tissue damage. The evidence supports the idea that regular, moderate activity helps keep the synovial environment healthier over the long term, while excessive or poorly timed loading can tip the balance toward more inflammation. If you have chronic joint disease, the specifics of your exercise program are worth discussing with a clinician who knows your joints, not just your cardiovascular fitness.